Efficacy of everolimus-based therapy in advanced triple-positive breast cancer: Experience from three cancer centers in China.

Yujing Tan Hanfang JiangFei MaJiayu WangPin ZhangQing LiXinzhu TianBinghe XuWeihong ZhaoYing Fan

Published in: Thoracic cancer (2023)

Everolimus as frontline treatment achieves clinical benefits for Chinese patients with mTPBC, which may provide some references for the management of Chinese mTPBC patients.

Keyphrases

positive breast cancer
end stage renal disease
newly diagnosed
ejection fraction
peritoneal dialysis
papillary thyroid
stem cells
young adults
bone marrow
cell therapy
childhood cancer